Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Gains from Investment Securities (2016 - 2025)

Harte Hanks (HHS) has disclosed Gains from Investment Securities for 16 consecutive years, with $310000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities rose 1.31% to $310000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.2 million, a 115.41% decrease, with the full-year FY2024 number at -$1.5 million, down 150.09% from a year prior.
  • Gains from Investment Securities was $310000.0 for Q3 2025 at Harte Hanks, down from $990000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $6.3 million in Q4 2023 to a low of -$4.8 million in Q1 2023.
  • A 5-year average of $209500.0 and a median of $251000.0 in 2024 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: soared 806.06% in 2021, then tumbled 2673.26% in 2023.
  • Harte Hanks' Gains from Investment Securities stood at -$1.1 million in 2021, then skyrocketed by 130.86% to $350000.0 in 2022, then soared by 1690.86% to $6.3 million in 2023, then crashed by 142.21% to -$2.6 million in 2024, then surged by 111.72% to $310000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Gains from Investment Securities are $310000.0 (Q3 2025), $990000.0 (Q2 2025), and $196000.0 (Q1 2025).